From Pioneer to the World's Leading Scientific Network

"Pioneers" was the headline when Science magazine covered the launch of the academic networking platform ResearchGATE exactly one year ago. In a very short time, a small group of pioneers in scientific communication, located at Harvard University and Hannover Medical School (Germany), has managed to create a worldwide community with more than 50,000 members from 196 countries.

In just twelve months, ResearchGATE has achieved its goal (called "ambitious" by Science magazine) of establishing itself as the world's leading social network for researchers focused on life sciences. Moreover, ResearchGATE offers far more than the usual networking features: Many different tools and applications greatly simplify scientific collaboration and research.

Within the platform, 1,100 issue-specific groups have been founded. Several research organizations and academic institutions cooperate with ResearchGATE, thereby contributing to the growing depth and reach of the platform. A new concept for sub-communities allows such organizations to create their own, closed "network within the network", ensuring confidentiality while giving members the opportunity for exchange with the global research community. Currently, this concept is carried out with the prestigious German Society for Virology (counting noble prize winner Harald zur Hausen into its ranks). Now, it will be made available to the entire scientific world.

By launching its semantic search engine for scientific literature and its automated matching processes, ResearchGATE has distanced typical Web 2.0 applications in terms of usability and member benefits. These tools enable researchers to find groups, papers, fellow researchers and everything else within and outside of ResearchGATE without having to read through dozens of irrelevant search results. The Similar Abstract Search Engine (SASE) allows users to upload entire abstracts and find thematically related papers within the platform and in external databases containing 30 million articles.

Moreover, individual users as well as groups of potential interest to the researcher are automatically suggested. File sharing, scheduling and voting tools add to the functionality of the platform.

Over the past twelve months, ResearchGATE's IT team has written more than 800,000 lines of code and installed 232 versions of ResearchGATE on its productive system. The feedback of members, the worldwide publicity and the constant requests from academic institutions seem to show that ResearchGATE is on the right path. Its value for members will continue to increase: Several cutting-edge tools and applications are scheduled to be released soon. Additional institutional cooperations will further enhance the quality of the network.

For further information, please visit:
http://www.researchgate.net

Most Popular Now

AstraZeneca enters license agreement with KYM Bios…

AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targetin...

Pfizer's elranatamab receives FDA and EMA filing a…

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application (BLA) ...

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Nanosatellite shows the way to RNA medicine of the…

The RNA molecule is commonly recognized as messenger between DNA and protein, but it can also be folded into intricate molecular machines. An example of a naturally occur...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...

AI conjures proteins that speed up chemical reacti…

For the first time, scientists have used machine learning to create brand-new enzymes, which are proteins that accelerate chemical reactions. This is an important step in...